Join
Live feed
·
PRReleasevia Quantisnow
GeneDx Holdings Corp. logo
Zevra Therapeutics Inc. logo

GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C

ByQuantisnow·Wall Street's wire, on your screen.
WGS· GeneDx Holdings Corp.ZVRA· Zevra Therapeutics Inc.
TechnologyHealth Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track WGS (GeneDx Holdings Corp.), ZVRA (Zevra Therapeutics Inc.) and more on Quantisnow.